Log in

Linagliptin

Anti-BP230-type bullous pemphigoid

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Wan L, et al. Anti-BP230-type bullous pemphigoid associated with linagliptin treatment: first case report in China. [Chinese] Chinese Journal of Dermatology 54 : 136-138, No. 2, Jan 2021. Available from: URL: https://dx.doi.org/10.35541/cjd.20200982 [Chinese; summarised from a translation]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Linagliptin. Reactions Weekly 1995, 107 (2024). https://doi.org/10.1007/s40278-024-53370-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-53370-4

Navigation